Gynecological Disorders Can Increase Risk for Cardiovascular, Cerebrovascular Disease
By Elana Gotkine HealthDay Reporter
FRIDAY, Feb. 28, 2025 -- Nonmalignant gynecological diseases (NMGD) are associated with cardiovascular and/or cerebrovascular disease (C/CVD), according to a systematic review and meta-analysis published online Feb. 24 in Heart.
Giorgia Elisabeth Colombo, M.B., Ch.B., from the Ospedale Regionale di Lugano in Switzerland, and colleagues conducted a systematic literature review to examine the association between NMGD and C/CVD. A combination of ischemic heart disease, cerebrovascular disease, heart failure, and peripheral vascular disease defined the composite C/CVD outcome.
The analysis included 28 studies, with 3,271,242 participants. The researchers found that 53.3 percent of the studies had a serious/critical risk for bias. Overall, individuals with NMGD had a significantly elevated risk for composite C/CVD (summary relative risk [SRR], 1.28; I2 = 65.3 percent), ischemic heart disease (SRR, 1.41; I2 = 73.7 percent), and cerebrovascular disease (SRR, 1.33; I2 = 91.5 percent). Those with a history of endometriosis or polycystic ovary syndrome had a greater risk for C/CVD and its components in NMGD-specific analyses.
"Physicians should be aware of the potential association between NMGD and C/CVD and use this to inform clinical practice in order to mitigate the risk of C/CVD," the authors write. "Our findings reinforce the need for prospective longitudinal life course research evaluating risk of C/CVD outcomes in NMGD overall and in subgroup populations, which may catalyze primary prevention strategies."
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Use of AI Can Help Identify Coronary Thin-Cap Fibroatheromas
TUESDAY, Sept. 2, 2025 -- An artificial intelligence (AI)-based image analysis can identify coronary thin-cap fibroatheromas (TCFAs), which are associated with adverse...
Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis
THURSDAY, Aug. 28, 2025 -- Spironolactone does not reduce a composite outcome of cardiovascular mortality and hospitalization due to heart failure among patients receiving...
Shared, Sex-Specific Body Fat Patterns Linked to Cardiovascular Aging
WEDNESDAY, Aug. 27, 2025 -- Shared and sex-specific patterns of body fat are associated with changes in cardiovascular aging, according to a study published online Aug. 22 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.